Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10579621rdf:typepubmed:Citationlld:pubmed
pubmed-article:10579621lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C0021756lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C0003964lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C0078058lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C1101536lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C0063717lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C0085083lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C0677026lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C1171892lld:lifeskim
pubmed-article:10579621lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:10579621pubmed:issue1lld:pubmed
pubmed-article:10579621pubmed:dateCreated1999-12-10lld:pubmed
pubmed-article:10579621pubmed:abstractTextTo investigate the possible role of vascular endothelial growth factor, interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6 and soluble interleukin-6 receptor in the pathogenesis of ovarian hyperstimulation syndrome.lld:pubmed
pubmed-article:10579621pubmed:languageenglld:pubmed
pubmed-article:10579621pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10579621pubmed:citationSubsetIMlld:pubmed
pubmed-article:10579621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10579621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10579621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10579621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10579621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10579621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10579621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10579621pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10579621pubmed:statusMEDLINElld:pubmed
pubmed-article:10579621pubmed:monthNovlld:pubmed
pubmed-article:10579621pubmed:issn0301-2115lld:pubmed
pubmed-article:10579621pubmed:authorpubmed-author:SerourG IGIlld:pubmed
pubmed-article:10579621pubmed:authorpubmed-author:ShaarawyMMlld:pubmed
pubmed-article:10579621pubmed:authorpubmed-author:AboulgharM...lld:pubmed
pubmed-article:10579621pubmed:authorpubmed-author:MansourR TRTlld:pubmed
pubmed-article:10579621pubmed:authorpubmed-author:El HelwB ABAlld:pubmed
pubmed-article:10579621pubmed:issnTypePrintlld:pubmed
pubmed-article:10579621pubmed:volume87lld:pubmed
pubmed-article:10579621pubmed:ownerNLMlld:pubmed
pubmed-article:10579621pubmed:authorsCompleteYlld:pubmed
pubmed-article:10579621pubmed:pagination81-5lld:pubmed
pubmed-article:10579621pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:meshHeadingpubmed-meshheading:10579621...lld:pubmed
pubmed-article:10579621pubmed:year1999lld:pubmed
pubmed-article:10579621pubmed:articleTitleElevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.lld:pubmed
pubmed-article:10579621pubmed:affiliationThe Egyptian IVF-ET Center, Maadi, Cairo.lld:pubmed
pubmed-article:10579621pubmed:publicationTypeJournal Articlelld:pubmed